Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study.
- DOI
- 10.1016/j.ctarc.2026.101200
- Published
- 2026
- Container
- Cancer treatment and research communications
- Publisher
- Not recorded
- Open access
- no
Credibility signals
uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101200,
title = {Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study.},
author = {Brandstetter LS and Grau A and Müller-Reiter M and Salmen J and Reese JP and Heuschmann PU and Wöckel A},
year = {2026},
journal = {Cancer treatment and research communications},
doi = {10.1016/j.ctarc.2026.101200},
url = {https://doi.org/10.1016/j.ctarc.2026.101200}
}RIS
TY - JOUR TI - Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study. AU - Brandstetter LS AU - Grau A AU - Müller-Reiter M AU - Salmen J AU - Reese JP AU - Heuschmann PU AU - Wöckel A PY - 2026 JO - Cancer treatment and research communications DO - 10.1016/j.ctarc.2026.101200 UR - https://doi.org/10.1016/j.ctarc.2026.101200 ER -
APA
LS, B., A, G., M, M., J, S., JP, R., PU, H., & A, W. (2026). Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101200
Source records
- pubmed · retrieved 2026-09-26T18:42:49.867Z
- europe-pmc · retrieved 2026-09-26T18:42:49.899Z
- doaj · retrieved 2026-09-26T18:42:49.882Z